JP Patent

JP7684902B2 — グルカゴン及びこれを含む組合せ物の治療学的用途

Assigned to ハンミファーマシューティカルカンパニーリミテッド · Expires 2025-05-28 · 1y expired

What this patent protects

Patent listed against Jardiance.

Drugs covered by this patent

Jardiance (empagliflozin) · Boehringer Ingelheim

Patent Metadata

Patent number: JP7684902B2
Jurisdiction: JP
Classification: —
Expires: 2025-05-28
Drug substance claim: No
Drug product claim: No
Assignee: ハンミファーマシューティカルカンパニーリミテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.